Markets:

Overview

News

Currencies

International

Treasuries

Bionano Genomics, Inc. - Common Stock (NQ:BNGO)

1.278 -0.192 (-13.03%)

Streaming Delayed Price Updated: 1:49 PM EST, Jan 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bionano Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Bionano Genomics Stock Is a Low-Priced Bet on Sound Science ↗

January 03, 2022

Even though BNGO stock investors struggled in 2021, prepare for new price discovery as Bionano pushes the envelope in optical genome mapping.

Via InvestorPlace

The Critics Are Wrong About Bionano Stock ↗

December 27, 2021

The critics of Bionano are greatly underestimating the vast potential of Saphyr and of BNGO stock for long-term investors.

Via InvestorPlace

This Analyst’s Saphyr Calculations Suggest Buying Bionano While It’s Down ↗

December 14, 2021

If BNGO stock reaches Oppenheimer’s price target, investors are looking at a return of more than 300%, plus long-term growth potential.

Via InvestorPlace

5 Penny Stocks Insiders Are Buying ↗

December 01, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and ...

Via Benzinga

Bionano Genomics Proves Not Everything Genetic is Gold ↗

December 01, 2021

Bionano sells a $150,000 machine called Saphyr that does genetic mapping. It's a solid device, but its future remains in the future, as do BNGO stock fortunes.

Via InvestorPlace

Unusual Options Activity Insight: Bionano Genomics ↗

August 06, 2021

Bionano Genomics (NASDAQ:BNGO) shares experienced unusual ...

Via Benzinga

Jim Cramer Shares His Thoughts On Chegg, Bristol-Myers Squibb And More ↗

November 30, 2021

On CNBC’s "Mad Money Lightning Round," Jim Cramer said with Matterport, Inc. (NASDAQ:

Via Benzinga

Wait for Bionano Stock to Fall Further Before Buying ↗

November 23, 2021

BNGO stock is breaking down following the latest earnings report, and there are no major catalysts to push shares up in the short term.

Via InvestorPlace

Bionano’s Is on Track for Growth Thanks to Saphyr ↗

November 19, 2021

BNGO stock beats analyst forecasts yet again. Flush with cash and with Saphyr installations rising, this stock remains a high potential play.

Via InvestorPlace

With Progress on Multiple Fronts, Bionano Genomics Stock Is Great Buy Here ↗

November 12, 2021

Bionano's acquisition of a software company makes Saphyr more attractive, and studies should result in insurers reimbursing those who use the system. BNGO stock is a buy.

Via InvestorPlace

Bionano Genomics, Inc (BNGO) Q3 2021 Earnings Call Transcript ↗

November 06, 2021

BNGO earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 02, 2021

Gainers Kiniksa Pharmaceuticals (NASDAQ:KNSA) stock increased by 16.73% to $14.86 during Tuesday's regular session. The current volume of 1.0 million shares is 269.7%...

Via Benzinga

2 Best Biotech Stocks to Buy in November ↗

November 01, 2021

Bionano Genomics and Ocugen could both be gearing up for a healthy rally this month.

Via The Motley Fool

Bionano Genomics Is Still Set to Pay Off Big for Patient Investors ↗

October 28, 2021

BNGO stock is no longer a fast money trade. But that's hardly a reason to skip out on it, given its massive potential.

Via InvestorPlace

Jim Cramer Prefers This Stock Over Mogo, Considers Endeavor Group As Inexpensive ↗

October 19, 2021

On CNBC’s "Mad Money Lightning Ro...

Via Benzinga

Bionano Genomics’ Latest Software Business Acquisition Adds Immense Value ↗

October 19, 2021

BNGO stock isn't a darling of the markets at the moment, but Bionano continues to advance its stature in the optical genome mapping niche.

Via InvestorPlace

Bionano Genomics Stock Looks Ready to Reward Patient Investors ↗

October 18, 2021

BNGO stock is down 25% since year to date. But as the company begins to deliver consistent revenue, a prudent investment may be rewarded.

Via InvestorPlace

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

What's Up With Bionano Genomics Today? ↗

October 12, 2021

Bionano Genomics Inc. (NASDAQ: BNGO) shares are trading higher Tuesday after the company announced it agreed to buy BioDiscovery Inc, a provider of software for analysis,...

Via Benzinga

BNGO Stock: The Big Acquisition News Sending Bionano Genomics Soaring ↗

October 12, 2021

Bionano has just made a deal that will help it secure a spot among biotech companies riding the wave of the current boom. BNGO stock is up.

Via InvestorPlace

Groundbreaking Tech Makes Bionano Genomics Look Better Than Ever ↗

October 07, 2021

Off and on the price chart, Bionano Genomics could be the next big thing in genomics with multiple catalysts for BNGO stock.

Via InvestorPlace

BNGO Stock: What Is Driving Bionano Genomics Higher Today? ↗

September 30, 2021

Today, investors in Bionano Genomics and BNGO stock are cheering some positive clinical trial data around optical genome mapping.

Via InvestorPlace

Bionano Genomics Remains Promising With Global Product Adoption ↗

September 21, 2021

BNGO stock has been stuck in a range, but its next move should be to the upside based on Bionano's breakthrough genome mapping system.

Via InvestorPlace

If You Invested $1,000 In BioNano Stock One Year Ago, Here's How Much You'd Have Now ↗

September 09, 2021

Investors who have owned stocks in the last year have generally experienced some big gains. In fact, the SPDR S&P 500 (NYSE: SPY) total return over the last 12 months is 37.1...

Via Benzinga

Topics Stocks

The Price Is Right for BioNano Genomics Given Saphyr’s Potential ↗

August 30, 2021

With its Saphyr system seeing adoption ramp up, the long-term growth potential for BNGO stock is considerable.

Via InvestorPlace

Bionano Stock Will Soar as the Company’s Diagnostic System Catches On ↗

August 18, 2021

As more payors reimburse labs for using Bionano's Saphyr device, the company's financial results will improve, lifting BNGO stock.

Via InvestorPlace

Faster and Better Clinical Outcomes Make the Case for Bionano Genomics ↗

August 05, 2021

Bionano Genomics is mastering the science of genome mapping, while a reduced-price BNGO stock has a clear path forward for investors.

Via InvestorPlace

Bionano Genomics, Inc (BNGO) Q2 2021 Earnings Call Transcript ↗

August 05, 2021

BNGO earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗

August 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Contact Us

Contact Us

Bionano Genomics, Inc. - Common Stock (NQ:BNGO)

All News about Bionano Genomics, Inc. - Common Stock